Research ArticleCancer

A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice

See allHide authors and affiliations

Science Translational Medicine  30 Mar 2011:
Vol. 3, Issue 76, pp. 76ra27
DOI: 10.1126/scitranslmed.3001069

Log in to view PDF

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine